Fondaparinux Injection Exporter from India | Manufacturer & Global Supplier

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Fondaparinux Injection is a synthetic anticoagulant used for the prevention and treatment of thromboembolic disorders such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It acts by selectively inhibiting Factor Xa, helping prevent blood clot formation and supporting effective anticoagulant therapy.

This formulation is widely used in patients undergoing orthopedic surgery and in individuals at risk of venous thromboembolism. Genliva Wellness LLP is a reliable Fondaparinux Injection Manufacturer in India, Fondaparinux Injection Exporter from India, and Fondaparinux Injection Contract Manufacturer in Gujarat, supplying high-quality injectable formulations to international pharmaceutical markets.

Fondaparinux Injection is formulated to provide effective and predictable anticoagulant activity.

Selective Factor Xa inhibitor
Synthetic anticoagulant formulation
Sterile injectable preparation
Predictable pharmacological response
Suitable for subcutaneous administration
Consistent product quality

Fondaparinux Injection is indicated for the prevention and treatment of thromboembolic conditions.

Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Venous thromboembolism prevention
Post-surgical thrombosis prophylaxis
Acute coronary syndrome management
Anticoagulant therapy in high-risk patients

Fondaparinux Injection helps reduce the risk of clot formation and supports effective anticoagulant management.

Effective prevention of blood clots
Selective inhibition of Factor Xa
Predictable anticoagulant effect
Supports post-surgical thrombosis prevention
Suitable for short and long-term therapy
Widely accepted in cardiovascular care